These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 27607910)

  • 21. Fetal and maternal outcome after hyperimmunoglobulin administration for prevention of maternal-fetal transmission of cytomegalovirus during pregnancy: retrospective cohort analysis.
    Seidel V; Hackelöer M; Rancourt RC; Henrich W; Siedentopf JP
    Arch Gynecol Obstet; 2020 Dec; 302(6):1353-1359. PubMed ID: 32754858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the prevention and treatment of congenital cytomegalovirus infections.
    Adler SP; Nigro G; Pereira L
    Semin Perinatol; 2007 Feb; 31(1):10-8. PubMed ID: 17317422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Describing the Impact of Maternal Hyperimmune Globulin and Valacyclovir on the Outcomes of Cytomegalovirus Infection in Pregnancy: A Systematic Review.
    Fitzpatrick A; Cooper C; Vasilunas N; Ritchie B
    Clin Infect Dis; 2022 Oct; 75(8):1467-1480. PubMed ID: 35438780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.
    Buxmann H; Stackelberg OM; Schlößer RL; Enders G; Gonser M; Meyer-Wittkopf M; Hamprecht K; Enders M
    J Perinat Med; 2012 Mar; 40(4):439-46. PubMed ID: 22752777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and safety of prenatal valacyclovir for congenital cytomegalovirus infection: systematic review and meta-analysis.
    D'Antonio F; Marinceu D; Prasad S; Khalil A
    Ultrasound Obstet Gynecol; 2023 Apr; 61(4):436-444. PubMed ID: 36484439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy or prevention of fetal infection by cytomegalovirus with immunoglobulin infusion in pregnant women with primary infection].
    Cosmi E; Mazzocco M; La Torre R; Ligi P; Sali E; Nigro G
    Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():547-51. PubMed ID: 11424804
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital cytomegalovirus infection.
    Leung AK; Sauve RS; Davies HD
    J Natl Med Assoc; 2003 Mar; 95(3):213-8. PubMed ID: 12749681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Significance of diagnostics and treatment in preventing congenital infections with Toxoplasma gondii (Tg), cytomegalovirus (CMV) and parvowirus B19 (PVB19)].
    Szenborn L
    Przegl Lek; 2010; 67(1):54-7. PubMed ID: 20509575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus: should we screen pregnant women for primary infection?
    Johnson JM; Anderson BL
    Am J Perinatol; 2013 Feb; 30(2):121-4. PubMed ID: 23292913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.
    Kagan KO; Enders M; Schampera MS; Baeumel E; Hoopmann M; Geipel A; Berg C; Goelz R; De Catte L; Wallwiener D; Brucker S; Adler SP; Jahn G; Hamprecht K
    Ultrasound Obstet Gynecol; 2019 Mar; 53(3):383-389. PubMed ID: 29947159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines on CMV congenital infection.
    Coll O; Benoist G; Ville Y; Weisman LE; Botet F; Anceschi MM; Greenough A; Gibbs RS; Carbonell-Estrany X;
    J Perinat Med; 2009; 37(5):433-45. PubMed ID: 19673682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the placenta in the pathogenesis of congenital cytomegalovirus infection: is the benefit of cytomegalovirus immune globulin for the newborn mediated through improved placental health and function?
    Schleiss MR
    Clin Infect Dis; 2006 Oct; 43(8):1001-3. PubMed ID: 16983611
    [No Abstract]   [Full Text] [Related]  

  • 33. Prevention of maternal-fetal transmission of cytomegalovirus.
    Adler SP; Nigro G
    Clin Infect Dis; 2013 Dec; 57 Suppl 4():S189-92. PubMed ID: 24257425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antenatal treatment options for primary cytomegalovirus infections.
    Kagan KO; Sonek J; Hamprecht K
    Curr Opin Obstet Gynecol; 2018 Dec; 30(6):355-360. PubMed ID: 30169462
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical outcome and the role of antivirals in congenital cytomegalovirus infection.
    Ross SA; Kimberlin D
    Antiviral Res; 2021 Jul; 191():105083. PubMed ID: 33964331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Congenital cytomegalovirus infections.
    Malm G; Engman ML
    Semin Fetal Neonatal Med; 2007 Jun; 12(3):154-9. PubMed ID: 17337260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current controversies in diagnosis, management, and prevention of congenital cytomegalovirus: updates for the pediatric practitioner.
    Harrison GJ
    Pediatr Ann; 2015 May; 44(5):e115-25. PubMed ID: 25996198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperimmune globulin to prevent congenital CMV infection.
    Nigro G
    N Engl J Med; 2014 Jun; 370(26):2544. PubMed ID: 24963585
    [No Abstract]   [Full Text] [Related]  

  • 39. Hyperimmune globulin to prevent congenital CMV infection.
    van Leeuwen E; Oude Rengerink K; Pajkrt E
    N Engl J Med; 2014 Jun; 370(26):2543-4. PubMed ID: 24963584
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperimmune globulin to prevent congenital CMV infection.
    Hamprecht K; Kagan KO; Goelz R
    N Engl J Med; 2014 Jun; 370(26):2543. PubMed ID: 24963583
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.